Skip to content
Open access

Increasing burden of multiple long-term conditions and mortality risk following COVID-19 diagnosis: a national cohort study of one million adults with cardiovascular disease in England.

Sep 2026 · Journal of public health · 0 citations · 22 references
Medicine

TL;DR

MLTCs burden was a stronger determinant of mortality risk than CVD subtype alone, andFindings support moving beyond single-disease models towards integrated, MLTC-informed care, and pandemic preparedness.

Abstract

Background

Individuals with cardiovascular disease (CVD) experienced high mortality during coronavirus disease 2019 (COVID-19), yet most live with multiple long-term conditions (MLTCs). We examined the association between MLTCs burden and mortality following COVID-19 among people with CVD.

Methods

In this population-based cohort study, linked national electronic health records from England were analysed. Adults aged ≥18 years with CVD and a positive COVID-19 test between 31 January 2020 and 31 October 2022 were included. MLTCs burden was defined as the number of additional long-term conditions beyond CVD (0, 1, 2, or ≥3). One-year mortality was assessed using adjusted flexible parametric Royston-Parmar models.

Results

In 1 081 695 individuals with CVD and COVID-19, 89.7% had at least one long-term condition (LTC) and 67.9% had two or more. Increasing MLTC burden showed a dose-response association with mortality. Compared to individuals without additional LTCs, mortality risk was doubled for those with one LTC (adjusted hazard ratio: 1.86, 95% CI: 1.76-1.96), tripled among those with two LTCs (3.00, 2.85-3.16), and five-fold higher in those with ≥3 LTCs (5.00, 4.75-5.27). Associations were consistent across CVD subtypes.

Conclusions

MLTCs burden was a stronger determinant of mortality risk than CVD subtype alone. Findings support moving beyond single-disease models towards integrated, MLTC-informed care, and pandemic preparedness.

Read PDF

Similar papers

Open access Sep 2026

How age and underlying conditions affect incidence of hospitalization and death after documented COVID-19 diagnosis among individuals aged >=20 years, a retrospective cohort study using PCORnet, April 2022 to March 2025

Abstract Background: COVID-19 vaccinations, therapeutics, and immunity from infection have reduced COVID-19 severity. It is unknown to what extent previously identified risk factors, age and underlying medical conditions (UC), remain associated with severe COVID-19 incidence. Methods: Using electronic health record (EH...

E. Koumans, G. Derado, M. Shah et al. · 0 citations
Open access Sep 2026

Increasing Multimorbidity Burden After COVID-19 Infection Among People With and Without HIV in the United States: Insights From the National Clinical Cohort Collaborative (N3C)

Abstract Background People with HIV (PWH) have a disproportionately high burden of chronic comorbidities. However, how their multimorbidity patterns differ from those of the general population and how COVID-19 infection may affect this burden have not been well characterized. Methods We conducted a retrospective cohort...

Yu-Meng Wang, Ahmed Sabit, J. Anzalone et al. · 0 citations
Open access Oct 2026

Long-COVID Associated With Incident Hypertension: A Population-Based Cohort Study.

BACKGROUND Long COVID has been linked to persistent autonomic and vascular abnormalities, but its impact on hypertension among non-hospitalized COVID-19 convalescents remains unclear. Given the link between blood pressure and cardiovascular morbidity, understanding how long COVID modifies the risk of incident hypertens...

P. Lindberg, Samuel Wiqvist, Seika Lee et al. · 0 citations
Open access Aug 2026

COVID-19 and long-term risk of incident laboratory-defined micronutrient deficiency in patients with type 2 diabetes: a multicenter propensity score–matched cohort study

Background COVID-19 has been linked to broad post-acute sequelae, but delayed micronutrient deficiency remains insufficiently characterized. Whether COVID-19 increases long-term risks of laboratory-defined vitamin D, magnesium, and vitamin B12 deficiencies among patients with type 2 diabetes mellitus is unclear. Method...

I.-W. Chen, Li-Chen Chang, Kuo-Chuan Hung · 0 citations
Open access Sep 2026

Long-term risk of incident dementia following documented COVID-19 among older adults with type 2 diabetes: a propensity score-matched cohort study

Background Type 2 diabetes mellitus (T2DM) is a well-established risk factor for dementia, and COVID-19 has been associated with persistent neurological and cognitive sequelae. However, whether this association extends beyond the early post-infection period among older adults with T2DM—a population with compounded vasc...

I.-W. Chen, Li-Chen Chang, C. Ho et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.